155 related articles for article (PubMed ID: 10576217)
1. 17Alpha-alkan (or alkyn) amide derivatives of estradiol as inhibitors of steroid-sulfatase activity.
Boivin RP; Labrie F; Poirier D
Steroids; 1999 Dec; 64(12):825-33. PubMed ID: 10576217
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.
Boivin RP; Luu-The V; Lachance R; Labrie F; Poirier D
J Med Chem; 2000 Nov; 43(23):4465-78. PubMed ID: 11087571
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol.
Ciobanu LC; Boivin RP; Luu-The V; Labrie F; Poirier D
J Med Chem; 1999 Jun; 42(12):2280-6. PubMed ID: 10377235
[TBL] [Abstract][Full Text] [Related]
4. 3Beta-sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors.
Ciobanu LC; Boivin RP; Luu-The V; Poirier D
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):15-26. PubMed ID: 12751816
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal compounds designed to mimic potent steroid sulfatase inhibitors.
Ciobanu LC; Luu-The V; Poirier D
J Steroid Biochem Mol Biol; 2002 Mar; 80(3):339-53. PubMed ID: 11948019
[TBL] [Abstract][Full Text] [Related]
6. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor.
Purohit A; Woo LW; Singh A; Winterborn CJ; Potter BV; Reed MJ
Cancer Res; 1996 Nov; 56(21):4950-5. PubMed ID: 8895749
[TBL] [Abstract][Full Text] [Related]
7. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
[TBL] [Abstract][Full Text] [Related]
8. Solid-phase parallel synthesis of 17alpha-substituted estradiol sulfamate and phenol libraries using the multidetachable sulfamate linker.
Ciobanu LC; Poirier D
J Comb Chem; 2003; 5(4):429-40. PubMed ID: 12857111
[TBL] [Abstract][Full Text] [Related]
9. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase.
Ciobanu LC; Luu-The V; Martel C; Labrie F; Poirier D
Cancer Res; 2003 Oct; 63(19):6442-6. PubMed ID: 14559834
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and steroid sulphatase inhibitory activity of C19- and C21-steroidal derivatives bearing a benzyl-inhibiting group.
Ciobanu LC; Boivin RP; Luu-The V; Poirier D
Eur J Med Chem; 2001; 36(7-8):659-71. PubMed ID: 11600235
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors.
Billich A; Nussbaumer P; Lehr P
J Steroid Biochem Mol Biol; 2000; 73(5):225-35. PubMed ID: 11070351
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo models for the evaluation of new inhibitors of human steroid sulfatase, devoid of residual estrogenic activity.
Shields-Botella J; Bonnet P; Duc I; Duranti E; Meschi S; Cardinali S; Prouheze P; Chaigneau AM; Duranti V; Gribaudo S; Rivière A; Mengual L; Carniato D; Cecchet L; Lafay J; Rondot B; Sandri J; Pascal JC; Delansorne R
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):327-35. PubMed ID: 12711019
[TBL] [Abstract][Full Text] [Related]
14. Sulfamoyloxy-substituted 2-phenylindoles: antiestrogen-based inhibitors of the steroid sulfatase in human breast cancer cells.
Golob T; Liebl R; von Angerer E
Bioorg Med Chem; 2002 Dec; 10(12):3941-53. PubMed ID: 12413846
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of estradiol derivatives with 16 alpha-(bromoalkylamide), 16 alpha-(bromoalkyl) or 16 alpha-(bromoalkynyl) side chain as inhibitors of 17 beta-hydroxysteroid dehydrogenase type 1 without estrogenic activity.
Pelletier JD; Poirier D
Bioorg Med Chem; 1996 Oct; 4(10):1617-28. PubMed ID: 8931931
[TBL] [Abstract][Full Text] [Related]
16. Chemical synthesis and evaluation of 17α-alkylated derivatives of estradiol as inhibitors of steroid sulfatase.
Fournier D; Poirier D
Eur J Med Chem; 2011 Sep; 46(9):4227-37. PubMed ID: 21782294
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
Selcer KW; Jagannathan S; Rhodes ME; Li PK
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
[TBL] [Abstract][Full Text] [Related]
18. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
19. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of 16β-derivatives of 3-(2-bromoethyl)-estra-1,3,5(10)-trien-17β-ol as inhibitors of 17β-HSD1 and/or steroid sulfatase for the treatment of estrogen-dependent diseases.
Lespérance M; Roy J; Djiemeny Ngueta A; Maltais R; Poirier D
Steroids; 2021 Aug; 172():108856. PubMed ID: 33945801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]